Karyopharm Therapeutics (KPTI) Technical (Analysis) Reports Karyopharm Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Karyopharm Therapeutics (KPTI)
Technical Analysis Report for NASDAQ stock KPTI Karyopharm Therapeutics. Dated: 25 Sep 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock KPTI Karyopharm Therapeutics then click here. or read Experts views on Karyopharm Therapeutics or Forecast & share price targets of Karyopharm Therapeutics
Karyopharm Therapeutics Opened at 1.73 and Closed at: 1.62, which is -6.79% of previous session's close. It moved within a range of 1.57 and 1.77
The session was a Bearish session with an average volume of 1467000, which is 53.83% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
- The stock has fallen, and its mid term trend is also negative and in a downtrend.
- The stock has fallen, and its long term trend is also negative and in a downtrend.
Support for tomorrow is 1.5 and resistance for tomorrow is 1.7
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 1.54, 1.45 resistance for tomorrow's hourly charts is 1.74, 1.85
10 Day SMA for Karyopharm Therapeutics (KPTI) is 1.73 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Karyopharm Therapeutics (KPTI) is 1.75 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Karyopharm Therapeutics (KPTI) is 2.93 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 6.05 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Karyopharm Therapeutics is 6.88 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Karyopharm Therapeutics is at 1.75 and 200 DMA is at 6.88, while 50 DMA and 100 DMA are at 2.93 and 6.05 respectively
Karyopharm Therapeutics (KPTI) moving average of 20 SMA is at 1.75 and 20 EMA is at 1.87
| Date | Closing Price | 20 SMA | 20 EMA |
| 25 Fri Sep | 1.62 | 1.75 | 1.87 |
| 24 Thu Sep | 1.73 | 1.77 | 1.9 |
| 23 Wed Sep | 1.75 | 1.78 | 1.92 |
| 22 Tue Sep | 1.82 | 1.79 | 1.94 |
| 21 Mon Sep | 1.86 | 1.79 | 1.95 |
| 18 Fri Sep | 1.88 | 1.8 | 1.96 |
Karyopharm Therapeutics (KPTI) moving average of 50 SMA is at 2.93 and 50 EMA is at 3.21
| Date | Closing Price | 50 SMA | 50 EMA |
| 25 Fri Sep | 1.62 | 2.93 | 3.21 |
| 24 Thu Sep | 1.73 | 3.09 | 3.27 |
| 23 Wed Sep | 1.75 | 3.24 | 3.33 |
| 22 Tue Sep | 1.82 | 3.4 | 3.39 |
| 21 Mon Sep | 1.86 | 3.56 | 3.45 |
| 18 Fri Sep | 1.88 | 3.73 | 3.51 |
Karyopharm Therapeutics (KPTI) moving average of 100 SMA is at 6.05 and 100 EMA is at 4.81
| Date | Closing Price | 100 SMA | 100 EMA |
| 25 Fri Sep | 1.62 | 6.05 | 4.81 |
| 24 Thu Sep | 1.73 | 6.13 | 4.87 |
| 23 Wed Sep | 1.75 | 6.2 | 4.93 |
| 22 Tue Sep | 1.82 | 6.28 | 4.99 |
| 21 Mon Sep | 1.86 | 6.35 | 5.05 |
| 18 Fri Sep | 1.88 | 6.41 | 5.11 |
Karyopharm Therapeutics (KPTI) moving average of 200 SMA is at 6.88 and 200 EMA is at 5.88
| Date | Closing Price | 200 SMA | 200 EMA |
| 25 Fri Sep | 1.62 | 6.88 | 5.88 |
| 24 Thu Sep | 1.73 | 6.9 | 5.92 |
| 23 Wed Sep | 1.75 | 6.92 | 5.96 |
| 22 Tue Sep | 1.82 | 6.94 | 6 |
| 21 Mon Sep | 1.86 | 6.96 | 6.04 |
| 18 Fri Sep | 1.88 | 6.98 | 6.08 |
111 Inc has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in 111 Inc, about 17.42% more returns!
Verastem Inc has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Verastem Inc, about 20.43% more returns!
Meridian Bioscience has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Meridian Bioscience, about 14.85% more returns!
Karyopharm Therapeutics has performed better than Solid Biosciences in short term. Holding Karyopharm Therapeutics could be a better choice for now!
Sintx Technologies has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Sintx Technologies, about 38.7% more returns!
Karyopharm Therapeutics has performed better than Pavmed Inc in short term. Holding Karyopharm Therapeutics could be a better choice for now!
Karyopharm Therapeutics has performed better than Minerva Neurosciences in short term. Holding Karyopharm Therapeutics could be a better choice for now!
Altimmune Inc has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Altimmune Inc, about 12.08% more returns!
Karyopharm Therapeutics has performed better than Accuray Incorporated in short term. Holding Karyopharm Therapeutics could be a better choice for now!
Ardelyx Inc has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Ardelyx Inc, about 3.13% more returns!
Biocryst Pharmaceuticals has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Biocryst Pharmaceuticals, about 0.84% more returns!
Compugen has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Compugen, about 4.91% more returns!
Dare Bioscience has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Dare Bioscience, about 18.78% more returns!
Electrocore Inc has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Electrocore Inc, about 28.84% more returns!
Helius Medical has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Helius Medical, about 39.01% more returns!
Icu Medical has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Icu Medical, about 7.57% more returns!
Karyopharm Therapeutics has performed better than Kura Oncology in short term. Holding Karyopharm Therapeutics could be a better choice for now!
Karyopharm Therapeutics has performed better than Meiragtx Holdings in short term. Holding Karyopharm Therapeutics could be a better choice for now!
Medicinova Inc has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Medicinova Inc, about 91.84% more returns!
Karyopharm Therapeutics Technical analysis of indicators
Price action analysis of Karyopharm Therapeutics (KPTI) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Karyopharm Therapeutics stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Karyopharm Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Karyopharm Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Karyopharm Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Karyopharm Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.74 and Karyopharm Therapeutics KPTI stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Karyopharm Therapeutics KPTI stock. Volume based technical analysis of Karyopharm Therapeutics KPTI stock is negative.
Karyopharm Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock KPTI Karyopharm Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And KPTI Experts View which covers a lot of information including buying and selling signals
KPTI future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Karyopharm Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Karyopharm Therapeutics (KPTI) Technical (Analysis) Reports Karyopharm Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance


